Pioglitazone use is associated with reduced risk of Parkinson’s disease in patients with diabetes: A systematic review and meta-analysis

MLA

Liudan Chen, et al. “Pioglitazone Use Is Associated with Reduced Risk of Parkinson’s Disease in Patients with Diabetes: A Systematic Review and Meta-Analysis.” Journal of Clinical Neuroscience, vol. 106, Dec. 2022, pp. 154–58. EBSCOhost, https://doi.org/10.1016/j.jocn.2022.10.023.

APA

Liudan Chen, Yangu Tao, Jianjun Li, & Mengru Kang. (2022). Pioglitazone use is associated with reduced risk of Parkinson’s disease in patients with diabetes: A systematic review and meta-analysis. Journal of Clinical Neuroscience, 106, 154–158. https://doi.org/10.1016/j.jocn.2022.10.023

Chicago

Liudan Chen, Yangu Tao, Jianjun Li, and Mengru Kang. 2022. “Pioglitazone Use Is Associated with Reduced Risk of Parkinson’s Disease in Patients with Diabetes: A Systematic Review and Meta-Analysis.” Journal of Clinical Neuroscience 106 (December): 154–58. doi:10.1016/j.jocn.2022.10.023.